Mar 1 |
Sana Biotechnology files for mixed shelf offering
|
Feb 29 |
Sana Biotechnology Non-GAAP EPS of -$0.35
|
Feb 29 |
Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
|
Feb 29 |
14 Stocks With Heavy Insider Buying In 2024
|
Feb 28 |
Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
|
Feb 19 |
Institutional investors are Sana Biotechnology, Inc.'s (NASDAQ:SANA) biggest bettors and were rewarded after last week's US$521m market cap gain
|
Feb 13 |
Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
|
Feb 12 |
Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
Feb 8 |
Sana Biotechnology down 5%, prices $165M offering
|
Feb 8 |
Sana Biotechnology Announces Pricing of Upsized Public Offering
|